ArticleBioactive materials2024

STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy.

Nguyen Thi Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.